Loading clinical trials...
Loading clinical trials...
The Collaborative Study Group Trial: The Effect of Sulodexide in Overt Type 2 Diabetic Nephropathy
Conditions
Interventions
Sulodexide
Placebo
Locations
3
United States
The Collaborative Study Group, Clinical Coordinating Center for U.S. and Canadian clinics, Rush University Medical Center
Chicago, Illinois, United States
The Collaborative Study Group, Clinical Coordinating Center for the Pacific Region, Monash Medical Center
Melbourne, Victoria, Australia
The Collaborative Study Group, Clinical Coordinating Center for European Clinics, University of Groningen
Groningen, Netherlands
Start Date
August 1, 2005
Primary Completion Date
March 1, 2008
Completion Date
March 1, 2008
Last Updated
March 19, 2021
NCT06843304
NCT01802034
NCT06833541
NCT06661174
NCT04931537
NCT06954090
Lead Sponsor
Keryx Biopharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions